PLEGRIDY Rx

Select the drug indication to add to your list

PLEGRIDY

Multiple sclerosis
Only 4 drugs may be compared at once

Generic Name and Formulations:

Peginterferon beta-1a 125mcg; per prefilled pen or syringe; soln for SC inj; preservative-free.

Company:

Biogen

Select therapeutic use:

Indications for PLEGRIDY:

Relapsing forms of multiple sclerosis (MS).

Adult:

Give by SC inj in abdomen, back of the upper arm, or thigh; rotate inj sites. Initially 63mcg on Day 1, increase to 94mcg on Day 15, then 125mcg on Day 29 and every 14 days thereafter. May give analgesics and/or antipyretics for flu-like symptoms.

Children:

Not established.

Warnings/Precautions:

Monitor for signs/symptoms of hepatic injury. Depression. Suicidal ideation. Consider discontinuing if depression or other severe psychiatric symptoms occur. Seizure disorder. Discontinue if serious allergic reactions occur. Significant cardiac disease; monitor for worsening condition at initiation and during treatment. Risk of thrombotic microangiopathy; discontinue if occurs. Monitor for infections, bleeding, anemia. Myelosuppression. Monitor CBCs with differential and platelets during treatment. Consider discontinuing if new autoimmune disorder develops. Severe renal impairment; monitor. Pregnancy (Cat.C). Nursing mothers.

Pharmacological Class:

Immunomodulator.

Adverse Reactions:

Inj site reactions (erythema, pain, pruritus), influenza-like illness, pyrexia, headache, myalgia, chills, asthenia, arthralgia; hepatic injury, seizures, anaphylaxis, CHF, hematologic or autoimmune disorders, inj site necrosis (suspend therapy if multiple lesions occur).

Note:

To enroll women exposed to Plegridy during pregnancy call (866) 810-1462 or visit https://www.plegridypregnancyregistry.com/.

Generic Availability:

NO

How Supplied:

Single-dose prefilled pen (0.5mL)—2; Single-dose prefilled syringe (0.5mL)—2; Starter Pack (pens and syringes)—2 (63mcg + 94mcg)

PLEGRIDY 2 pens of 125mcg packages (Qty:1)

appx. price $6422.00